ChartWise Medical Systems Offers Sneak Peak of Next Generation Reporting Capabilities at 2016 AHIMA Convention
October 12, 2016 07:30 ET
|
ChartWise Medical Systems, Inc.
WAKEFIELD, RI--(Marketwired - October 12, 2016) - ChartWise Medical Systems, Inc. (www.chartwisemed.com), the award-winning industry leader in Computer-Assisted Clinical Documentation Improvement...
ChartWise Medical Systems Recognized on the Inc. 5000 List as One of America's Fastest-Growing Private Companies
August 18, 2016 08:30 ET
|
ChartWise Medical Systems, Inc.
WAKEFIELD, RI--(Marketwired - August 18, 2016) - ChartWise Medical Systems, Inc. (www.chartwisemed.com), the award-winning industry leader in Computer-Assisted Clinical Documentation Improvement...
Summit’s Ridinilazole Preserves Microbiome During Treatment of C. Difficile Infection
June 20, 2016 12:30 ET
|
Summit Therapeutics PLC
Microbiome-Sparing Action of Ridinilazole associated with Superiority over Vancomycin in Sustained Clinical Response Rate OXFORD, United Kingdom, June 20, 2016 (GLOBE NEWSWIRE) -- Summit...
Summit to Present Phase 2 CoDIFy Trial Data Highlighting Ridinilazole's Preservation of the Microbiome in CDI Patients at ASM Microbe 2016
May 23, 2016 07:00 ET
|
Summit Therapeutics plc
OXFORD, United Kingdom, May 23, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), the drug discovery and development company advancing therapies for Duchenne muscular...
Positive Results From Summit's Phase 2 CoDIFy Trial Highlight Potential of Ridinilazole in the Treatment of C. difficile Infection
April 11, 2016 07:00 ET
|
Summit Therapeutics plc
OXFORD, United Kingdom, April 11, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular...
Summit Therapeutics Announces Publication of Preclinical Data Showing Ridinilazole Outperformed Standard of Care in Reducing C. Difficile Toxins That Drive Disease Symptoms
February 24, 2016 07:00 ET
|
Summit Therapeutics plc
OXFORD, United Kingdom, Feb. 24, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne...
ChartWise Medical Systems Scores Again With Best in KLAS Report Award Win
February 17, 2016 08:30 ET
|
ChartWise Medical Systems, Inc.
WAKEFIELD, RI--(Marketwired - February 17, 2016) - ChartWise Medical Systems, Inc. (www.chartwisemed.com), the industry leader in Computer-Assisted Clinical Documentation Improvement (CACDI)...
Summit Therapeutics Granted Key European Patent for Novel Antibiotic Ridinilazole for Treatment of C. Difficile Infection
January 19, 2016 07:00 ET
|
Summit Therapeutics plc
OXFORD, UK, Jan. 19, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and...
Summit Therapeutics Reports Financial Results for the Third Quarter Ended 31 October 2015 and Operational Progress
December 17, 2015 07:00 ET
|
Summit Therapeutics plc
OXFORD, United Kingdom, Dec. 17, 2015 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), the drug discovery and development company advancing therapies for Duchenne muscular...
Three Associa CDI Managers Earn Industry Certification
November 24, 2015 12:03 ET
|
Associa
GOLDEN VALLEY, Minn., Nov. 24, 2015 (GLOBE NEWSWIRE) -- Community Development, Inc. (CDI), an Associa company, is proud to announce that three of its association managers recently attained their...